Bloomsbury Genetic Therapies Limited’s £5 Million Seed Financing

Osborne Clarke advised UCL Technology Fund on the investment.Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from rare…

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

This content is for Standard 1 Year members only.
Login Join Now